KalVista Pharma Stock (NASDAQ: KALV) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 346.80K |
Day Range | - - - |
52 Wk Range | 7.21 - 16.88 |
Market Cap | $618.38M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 61 |
Short Interest | 14.5% |
Days to Cover | 10.61 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of KalVista Pharma (NASDAQ:KALV) through any online brokerage.
Other companies in KalVista Pharma’s space includes: Celcuity (NASDAQ:CELC), Larimar Therapeutics (NASDAQ:LRMR), Replimune Group (NASDAQ:REPL), Sage Therapeutics (NASDAQ:SAGE) and Fate Therapeutics (NASDAQ:FATE).
There is no analysis for KalVista Pharma.
KalVista Pharma has a consensus price target of $24.80.
The stock price for KalVista Pharma (NASDAQ: KALV) is $14.47 last updated July 24, 2024 at 4:00 PM EDT.
There are no upcoming dividends for KalVista Pharma.
KalVista Pharma’s Q1 earnings are confirmed for Thursday, September 5, 2024.
There is no upcoming split for KalVista Pharma.
KalVista Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.